The Effectiveness of Systane PRO Preservative Free Verses Blink Triple Care Preservative Free

Part of paid clinical trials in La Jolla, California.

Sponsor
Gordon Schanzlin New Vision
Study ID
NCT07745062
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

  • Dry Eye Disease (DED)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Systane PRO — DRUG
    Administer Systane Pro PF QID OU over a period of 30 days
  • Blink tears — DRUG
    Administer Blink Triple Care PF QID OU over a period of 30 days

Study Details

The goal of this investigational study is to determine if Systane PRO Preservative Free is non-inferior to BLINK TRIPLE CARE in the clinically significant improvement of signs and symptoms of dry eye in patients over 4 weeks.

Key Dates

First listed
Aug 4, 2026
Start date
Jul 17, 2026
Status verified
Jul 2026
Primary completion
Jan 1, 2027
Completion
Apr 1, 2027

Study Design

Enrollment
30 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT

Arms

  • Active Comparator: BLINK TRIPLE CARE PF
    administer Blink Triple care PF QID OU over a period of 30 days
  • Experimental: Systane PRO PF
    Administer Systane Pro PF QID OU over a period of 30 days

Primary Outcome Measure

Ocular Surface Disease Index (OSDI) [ Time Frame: 30 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Gordon Schanzlin New Vision InstituteLa JollaCalifornia92037
Rylee Owen
[email protected]
858-455-6800
David I Geffen, Doctor Of Optometry (PRINCIPAL_INVESTIGATOR)

Find similar trials in La Jolla, CA

By research site
Gordon Schanzlin New Vision Institute· La Jolla, CA

Related Studies